Skip to main content

G71.14 vs M60

G71.14 (Drug induced myotonia) compared with M60 (Myositis), from the official CMS tabular data.

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources

Summary

These codes can be reported together when both conditions are documented, because G71.14 lists M60 under Excludes2, which marks them as distinct conditions.

Official rule
What is different?

The conditions named, billing status and chapter.G71.14 is “Drug induced myotonia”; M60 is “Myositis”. M60 is a non-billable header; G71.14 is billable. G71.14 sits in G00-G99 — Diseases of the Nervous System (G00-G99); M60 in M00-M99 — Diseases of the Musculoskeletal System and Connective Tissue (M00-M99).

Registry fact

Can these codes be reported together?

Yes, when both are documented.G71.14 lists M60 under Excludes2: “myositis (M60.-)”. Excludes2 marks distinct conditions that may both be reported when both are documented.

Official ruleGuide: Excludes1 vs Excludes2

Is there an Excludes1 relationship?

None.Neither entry carries an Excludes1 note that names the other code. M60 carries 7 Excludes1 notes covering other codes; the side-by-side table quotes them.

Official rule

Is there an Excludes2 relationship?

Yes.G71.14’s tabular entry: “myositis (M60.-)”. The note covers M60.

Official ruleGuide: Excludes1 vs Excludes2

Is one more specific?

Not comparable.The codes sit in different categories; specificity is only comparable within one category.

Is one a parent or header code?

One is a header.M60 is a non-billable header, but G71.14 is not one of its subdivisions.

Registry fact

Are there sequencing instructions?

None.Neither entry carries a Code First or Use Additional Code note that names the other.

Official rule

Are there other coding relationships?

None found.No laterality, encounter-phase, Table of Neoplasms, Table of Drugs and Chemicals, or history-versus-active-disease relationship links these codes.

MedCoder-derived

Official rule: a tabular instructional note or a section of the ICD-10-CM Official Guidelines, quoted as published. Registry fact: the codes’ own published attributes (titles, billable status, position in the hierarchy, code set). MedCoder-derived: a reading MedCoder computes from those facts; it is not itself a rule. How to read the labels

Can these codes be reported together?

Informational

Excludes2 relationship

G71.14
Drug induced myotonia
↔
M60
Myositis

What we found

Yes, when both are documented.G71.14 carries an Excludes2 note covering M60: “myositis (M60.-)”

Excludes2 marks distinct conditions — both may be reported when both are documented.

What to review

Report both only when the documentation supports both conditions; otherwise report the one documented.

Guide: Excludes1 vs Excludes2Check these on a claim

Why it matters

An Excludes2 note means the excluded condition is not part of the code above it, but a patient can have both. Report both when both are documented.

Source / rule

CMS ICD-10-CM tabular instructional notes

Official guidance behind these answers

  • Section I.A.12.b — Excludes2 · applies to: Excludes2

    A type 2 Excludes note represents “Not included here.” An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.

    ICD-10-CM Official Guidelines FY2027

Quoted from the ICD-10-CM Official Guidelines for Coding and Reporting in effect for the release shown. The tabular notes above are the code-level instruction; these sections are the convention that says how such a note is applied. Source document (CMS PDF) · Release and checksum

Side by side

Similar descriptions do not make codes interchangeable. The documentation and the official instructions decide which code applies.

Official descriptionDiffers
G71.14

Drug induced myotonia

M60

Myositis

StatusDiffers
G71.14
Billable
M60
Non-billable header

A header is not reported on a claim; a code beneath it is.

Report instead: M60.000, M60.001, M60.002, M60.003, M60.004

Excludes1Differs
G71.14

None at this code

M60
  • dermatopolymyositis (M33.-)
  • myopathy in amyloidosis (E85.-)
  • myopathy in polyarteritis nodosa (M30.0)
  • myopathy in rheumatoid arthritis (M05.32)
  • myopathy in scleroderma (M34.-)
  • myopathy in Sjögren's syndrome (M35.03)
  • myopathy in systemic lupus erythematosus (M32.-)
Excludes2Differs
G71.14
  • arthrogryposis multiplex congenita (Q74.3)
  • metabolic disorders (E70-E88)
  • myositis (M60.-)
M60
  • inclusion body myositis [IBM] (G72.41)
  • muscular dystrophies and myopathies (G71-G72)
Use additional codeDiffers
G71.14
  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
M60

None at this code

CategoryDiffers
G71.14

G71 Primary disorders of muscles

M60

Is itself a category

ChapterDiffers
G71.14

G00-G99 — Diseases of the Nervous System (G00-G99)

M60

M00-M99 — Diseases of the Musculoskeletal System and Connective Tissue (M00-M99)

No Code first, Code also, Includes and 7th character note at either code.

Notes are the code’s own tabular entry, quoted as published. A note that names the other code is the one the verdict above rests on. In a row that differs, notes every code shares are dimmed.

Edit this comparisonCheck a whole claim

Derived from the official CMS ICD-10-CM tabular data (FY2027). A coding-rule comparison, not billing advice: payer-specific edits and medical-necessity policy are outside its scope. All data sources